GO:0032903 regulation of nerve growth factor production: Neurotrophin Synthesis Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032903 describes any biological process that modulates the frequency, rate, or extent of production of nerve growth factor (NGF), a critical neurotrophin.
• NGF production is regulated in a cell-type-specific manner, with macrophages, keratinocytes, osteoblasts, and reproductive tissues among the key sources.
• Dysregulated NGF production is implicated in hepatocellular carcinoma progression and resistance to lenvatinib, as well as in burn wound healing and osteoarthritis.
• Key regulatory inputs include histamine, leptin receptor signaling, and inflammatory cytokines that tune NGF synthesis in peripheral tissues.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of genes controlling NGF production.
• Understanding GO:0032903 offers therapeutic opportunities in oncology, wound repair, bone regeneration, and neurobehavioral disorders.
Description
Nerve growth factor (NGF) is the founding member of the neurotrophin family and a secreted protein essential for the survival, differentiation, and maintenance of sympathetic and sensory neurons. Beyond the nervous system, NGF is produced by a variety of non-neuronal cell types and acts as a pleiotropic signaling molecule in immune, skeletal, reproductive, and integumentary tissues. The Gene Ontology term GO:0032903, regulation of nerve growth factor production, captures the diverse cellular processes that control the frequency, rate, or extent of NGF synthesis and release. This regulatory node is critical because NGF levels must be tightly balanced: insufficient NGF contributes to neurodegeneration and impaired tissue repair, whereas excessive NGF signaling promotes pathological innervation, pain, and tumor progression. Researchers study GO:0032903 to understand how extracellular cues and intracellular transcriptional programs converge on NGF gene expression and protein secretion. For example, histamine enhances NGF production in human keratinocytes, linking allergic and inflammatory skin responses to neurotrophic support. In bone marrow, leptin receptor-positive cells synthesize NGF to promote innervation and regeneration, demonstrating a role for metabolic signaling in NGF regulation. In osteoarthritis, macrophages in the synovium produce NGF, contributing to joint pain and disease progression. These findings underscore that regulation of NGF production is not a single pathway but a convergence point for immune, endocrine, and neuronal signals. The biomedical importance of GO:0032903 extends to cancer. Activation of NGF signaling limits the response to lenvatinib in hepatocellular carcinoma, suggesting that tumor-derived or microenvironment-derived NGF production can drive therapeutic resistance. In burn wound healing, NGF interacts with skin cells to modulate repair processes, and its production is dynamically regulated after injury. Thus, GO:0032903 is a research priority for understanding tissue homeostasis, disease mechanisms, and the development of targeted interventions.
regulation of nerve growth factor production At A Glance
| GO ID | GO:0032903 |
|---|---|
| GO term | regulation of nerve growth factor production |
| Ontology | biological_process |
| Synonym | regulation of beta-nerve growth factor production; regulation of NGF production |
| Definition | Any process that modulates the frequency, rate, or extent of production of nerve growth factor (NGF). |
| Major function | Controls the availability of NGF, a neurotrophin critical for neuronal survival, immune modulation, and tissue repair. |
| Key cell types | Macrophages, keratinocytes, osteoblasts, leptin receptor-positive bone marrow cells, reproductive tissues. |
| Regulatory inputs | Histamine, leptin signaling, inflammatory cytokines, and tissue injury. |
| Disease relevance | Hepatocellular carcinoma, osteoarthritis, burn wound healing, neurobehavioral disorders. |
What Is GO:0032903?
GO:0032903, regulation of nerve growth factor production, is defined as any process that modulates the frequency, rate, or extent of production of nerve growth factor (NGF). This biological process encompasses transcriptional, post-transcriptional, and secretory control mechanisms that determine how much mature NGF is made available by a cell. It includes both positive and negative regulation and applies to diverse cell types, from neurons to immune cells and keratinocytes.
Why Is regulation of nerve growth factor production Important in Cell Biology?
GO:0032903 is important because NGF is a pleiotropic factor whose production must be precisely controlled to maintain neuronal health and peripheral tissue homeostasis. Dysregulation of NGF production contributes to cancer progression, chronic pain, impaired wound healing, and bone regeneration defects. Understanding the regulatory mechanisms enables the design of targeted therapies that modulate NGF levels rather than globally inhibiting or supplementing the factor.
• NGF is essential for the survival and maintenance of sympathetic and sensory neurons.
• Regulation of NGF production in macrophages contributes to osteoarthritis pathology and pain.
• Leptin receptor-positive bone marrow cells produce NGF to promote innervation and regeneration.
• Histamine enhances NGF production in keratinocytes, linking inflammation to neurotrophic support.
• NGF production is dynamically regulated during burn wound healing and affects skin cell behavior.
• Activation of NGF signaling limits lenvatinib response in hepatocellular carcinoma.
• NGF plays a role in neurobehavioral regulation in adult vertebrates.
• NGF and its regulation are relevant to animal reproduction.
• Targeting NGF production pathways may offer therapeutic strategies for cancer, pain, and tissue repair.
• CRISPR-based models enable causal testing of genes that regulate NGF production.
What Happens During regulation of nerve growth factor production?
Transcriptional Control of NGF Gene Expression
In simple terms: The cell decides how much NGF mRNA to make by turning the NGF gene on or off.
Regulation of NGF production begins with transcriptional control of the NGF gene (NGF). Various extracellular signals, including histamine, can activate transcription factors that bind to the NGF promoter and enhance mRNA synthesis in keratinocytes. In bone marrow, leptin receptor signaling in specific stromal cells drives NGF expression to support innervation and regeneration. This step determines the potential output of NGF protein and is a major node for cell-type-specific regulation.
Post-Transcriptional and Translational Regulation
In simple terms: After mRNA is made, the cell can still adjust how much protein is produced.
Following transcription, NGF mRNA stability and translation efficiency can be modulated by microRNAs and RNA-binding proteins. Although specific mechanisms in the context of GO:0032903 are not fully detailed in the provided literature, general principles of neurotrophin regulation suggest that post-transcriptional control contributes to the fine-tuning of NGF output. This layer allows rapid changes in NGF production in response to inflammatory or injury signals.
Proteolytic Processing and Secretion
In simple terms: NGF is made as a precursor that must be cut and released to become active.
NGF is synthesized as a precursor protein, proNGF, which undergoes proteolytic cleavage to yield mature NGF. The regulation of this processing and subsequent secretion determines the amount of bioactive NGF available to target cells. In macrophages within osteoarthritic synovium, NGF production and release are thought to be regulated in response to local inflammatory cues. Secretion can be constitutive or regulated, depending on the cell type and physiological context.
Feedback and Signaling Integration
In simple terms: Once NGF is released, it can signal back to the cell or to neighbors to adjust production.
NGF can act in an autocrine or paracrine manner to modulate its own production or that of other cells. For example, in hepatocellular carcinoma, activation of NGF signaling limits the response to lenvatinib, suggesting that NGF signaling pathways feed back into tumor cell behavior. In burn wounds, NGF interacts with skin cells to influence healing, indicating that NGF production is integrated with downstream signaling events. This feedback ensures that NGF levels are matched to tissue demand.
Key Genes Involved in GO:0032903 regulation of nerve growth factor production
The following genes and proteins are experimentally implicated in the regulation of nerve growth factor production, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NGF | Encodes the nerve growth factor protein; its transcription and processing are the core of GO:0032903. | Central to all studies of NGF production; target for knockout and overexpression models. |
| LEPR | Leptin receptor; signaling in bone marrow cells promotes NGF synthesis and innervation. | Key regulator in bone regeneration and marrow innervation. |
| H1R (HRH1) | Histamine receptor; mediates histamine-enhanced NGF production in keratinocytes. | Links allergic inflammation to NGF production. |
| IL1B | Pro-inflammatory cytokine; can induce NGF production in various cell types. | Implicated in osteoarthritis and wound healing. |
| TNF | Tumor necrosis factor; modulates NGF expression in inflammatory conditions. | Relevant to synovial macrophages and skin inflammation. |
| NTRK1 (TrkA) | High-affinity NGF receptor; mediates downstream signaling that can feedback on NGF production. | Target for understanding NGF signaling loops in cancer and neurons. |
| NGFR (p75) | Low-affinity NGF receptor; modulates NGF responses and may influence production. | Studied in neurobehavioral and injury contexts. |
| MMP9 | Matrix metalloproteinase; may process proNGF to mature NGF. | Potential regulator of NGF bioavailability in wounds. |
| FURIN | Proprotein convertase; cleaves proNGF to mature NGF. | Enzyme critical for NGF maturation. |
| VEGFA | Angiogenic factor; may interact with NGF pathways in bone marrow. | Studied in bone regeneration and innervation. |
| BDNF | Another neurotrophin; can be co-regulated with NGF in some contexts. | Comparative studies of neurotrophin production. |
| STAT3 | Transcription factor; downstream of cytokine signaling that may regulate NGF transcription. | Potential mediator of inflammatory NGF induction. |
| NFKB1 | Transcription factor; activated by inflammatory signals that enhance NGF production. | Links inflammation to NGF synthesis. |
| MAPK1 (ERK2) | Kinase; signaling pathway that can modulate NGF expression. | Downstream of growth factor and leptin signaling. |
| CREB1 | Transcription factor; binds to cAMP response elements in the NGF promoter. | Mediates NGF induction by various stimuli. |
| EP300 | Transcriptional co-activator; enhances NGF gene transcription. | Epigenetic regulation of NGF production. |
How Is regulation of nerve growth factor production Regulated?
Regulation of NGF production is itself a regulated process. Key inputs include histamine, which enhances NGF production in human keratinocytes through H1 receptor signaling. Leptin receptor-positive cells in the bone marrow synthesize NGF in response to metabolic and regenerative cues, linking energy status to innervation. Inflammatory cytokines such as IL-1β and TNF can stimulate NGF production in macrophages and synovial cells, contributing to osteoarthritis pathology. In burn wounds, NGF production is dynamically regulated by skin cells and inflammatory mediators to promote healing. These diverse signals converge on transcriptional and post-transcriptional mechanisms to fine-tune NGF output.
regulation of nerve growth factor production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NGF | Hepatocellular carcinoma (lenvatinib resistance) | NGF knockout or overexpression in HCC cell lines |
| NGF | Osteoarthritis | Macrophage-specific NGF knockout in mouse models |
| NGF | Burn wound healing | Keratinocyte-specific NGF overexpression or knockout |
| LEPR | Bone marrow innervation and regeneration | Leptin receptor knockout mice |
| HRH1 | Histamine-induced NGF production in skin | HRH1 knockout keratinocytes |
Hepatocellular Carcinoma and Therapeutic Resistance
Activation of NGF signaling limits the response to lenvatinib in hepatocellular carcinoma, indicating that NGF production within the tumor microenvironment may contribute to drug resistance. This suggests that targeting the regulation of NGF production could sensitize tumors to lenvatinib. Further research is needed to identify the specific cell types and regulatory pathways responsible for NGF production in liver cancer.
Osteoarthritis and Joint Pain
Macrophages in osteoarthritic synovium produce NGF, and this production is thought to contribute to pain and disease progression. Understanding how NGF production is regulated in these immune cells may lead to new strategies for managing osteoarthritis. The regulation of NGF production by inflammatory mediators is a key area of investigation.
Burn Wound Healing and Skin Repair
NGF and its regulation play a significant role in burn wound healing through interactions with skin cells. Dysregulated NGF production can impair or delay healing. Modulating NGF production pathways may offer therapeutic benefits for burn patients, although precise mechanisms require further study.
Neurobehavioral and Reproductive Biology
NGF is involved in neurobehavioral regulation in adult vertebrates, and its production is relevant to animal reproduction. Alterations in NGF production may affect behavior and reproductive functions. These areas highlight the broad physiological importance of GO:0032903 beyond classical neurotrophic roles.
From regulation of nerve growth factor production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is NGF required for tumor resistance to lenvatinib? | NGF knockout hepatocellular carcinoma cell lines |
| Does leptin receptor signaling control NGF production in bone marrow? | Leptin receptor knockout mice |
| How does histamine regulate NGF production in keratinocytes? | HRH1 point mutation or knockout in human keratinocytes |
| What is the role of NGF in osteoarthritis pain? | Macrophage-specific NGF overexpression or knockout in mice |
| Does NGF production affect burn wound healing? | Keratinocyte-specific NGF knock-in or knockout in skin models |
| Can NGF production be modulated by inflammatory cytokines? | IL1B or TNF knockout macrophages |
How to Study the regulation of nerve growth factor production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcriptome changes | Identify pathways regulating NGF mRNA |
| qRT-PCR | NGF mRNA levels | Validate transcriptional changes |
| ELISA | Secreted NGF protein | Quantify NGF production in conditioned media |
| Western blot | Intracellular NGF protein | Assess proNGF and mature NGF |
| ChIP-seq | Transcription factor binding | Map NGF promoter regulation |
| CRISPR knockout | Gene function loss | Test candidate regulators of NGF production |
| Reporter assay | NGF promoter activity | Monitor NGF transcription in live cells |
| Immunohistochemistry | NGF localization in tissues | Identify NGF-producing cells in disease |
Transcriptional and Post-Transcriptional Analysis
RNA-seq and quantitative RT-PCR can measure NGF mRNA levels under different conditions to assess transcriptional regulation. Chromatin immunoprecipitation (ChIP) can identify transcription factors bound to the NGF promoter. These methods help define the regulatory inputs that control NGF production.
Protein Quantification and Secretion Assays
ELISA and Western blotting can quantify intracellular and secreted NGF protein. Conditioned media from cultured cells can be analyzed to measure NGF release. These approaches are essential for determining how regulation affects the amount of bioactive NGF produced.
Genetic Perturbation with CRISPR
CRISPR-Cas9 knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate genes in NGF production. For example, knocking out LEPR in bone marrow cells can test its role in NGF synthesis. These models provide definitive evidence of gene function in the context of GO:0032903.
Imaging and Reporter Systems
Reporter genes driven by the NGF promoter can be used to monitor NGF production in live cells. Immunohistochemistry can localize NGF-producing cells in tissues. These methods provide spatial and temporal information about NGF regulation.
How CRISPR Can Be Used to Study GO:0032903 regulation of nerve growth factor production
Knockout
CRISPR knockout of candidate genes such as LEPR or HRH1 can determine whether they are required for NGF production in specific cell types. Knockout models provide loss-of-function evidence and can be used in cell lines or primary cells to study GO:0032903.
Point Mutation
Introducing point mutations in regulatory regions of the NGF gene or in signaling molecules can dissect specific phosphorylation sites or DNA binding motifs that control NGF production. This approach offers fine-grained mechanistic insight.
Knock-in
Knock-in of reporter genes (e.g., GFP) under the NGF promoter allows real-time monitoring of NGF production. Tagged knock-in of NGF itself can facilitate tracking of protein trafficking and secretion.
Overexpression
Overexpression of NGF or upstream regulators can test sufficiency for increased NGF production. This is useful for modeling diseases where NGF levels are elevated, such as certain cancers or inflammatory conditions.
How EDITGENE Supports regulation of nerve growth factor production Research
Researchers studying regulation of nerve growth factor production-related genes often need to determine whether a candidate gene is causally involved in controlling NGF levels. EDITGENE provides comprehensive CRISPR-based services to enable such investigations with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of nerve growth factor production research.
Frequently Asked Questions About regulation of nerve growth factor production
What is GO:0032903?
GO:0032903 is the Gene Ontology term for regulation of nerve growth factor production, defined as any process that modulates the frequency, rate, or extent of production of nerve growth factor (NGF).
What genes are involved in regulation of nerve growth factor production?
Key genes include NGF itself, LEPR, HRH1, IL1B, TNF, and NTRK1, among others, as identified in studies of bone marrow, skin, and synovium.
How is NGF production regulated in keratinocytes?
Histamine enhances NGF production in human keratinocytes through H1 receptor signaling, linking allergic inflammation to neurotrophic support.
What role does NGF production play in osteoarthritis?
Macrophages in osteoarthritic synovium produce NGF, which contributes to joint pain and disease progression.
Can NGF production be studied with CRISPR?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes that regulate NGF production.
Why is regulation of NGF production important in cancer?
Activation of NGF signaling limits the response to lenvatinib in hepatocellular carcinoma, suggesting NGF production contributes to drug resistance.
What cells produce nerve growth factor?
NGF is produced by diverse cell types including macrophages, keratinocytes, osteoblasts, leptin receptor-positive bone marrow cells, and reproductive tissues.
How does NGF production affect wound healing?
NGF interacts with skin cells to modulate burn wound healing, and its production is dynamically regulated after injury.
Is NGF production relevant to neurobehavioral regulation?
Yes, NGF plays a role in neurobehavioral regulation in adult vertebrates, and its production is important for these functions.
What methods are used to study regulation of NGF production?
Common methods include RNA-seq, qRT-PCR, ELISA, Western blot, ChIP-seq, and CRISPR-based genetic perturbation.
Conclusion
GO:0032903, regulation of nerve growth factor production, is a critical biological process that controls the availability of a pleiotropic neurotrophin. Its dysregulation is implicated in cancer, osteoarthritis, impaired wound healing, and neurobehavioral disorders. Understanding the genes and pathways that regulate NGF production offers opportunities for therapeutic intervention. CRISPR-based models and advanced omics technologies are powerful tools to dissect this process and identify new targets.
References
- 1. Xu M et al.. 2026. Activation of Nerve Growth Factor signaling limits the response to lenvatinib in hepatocellular carcinoma.. Signal Transduct Target Ther 11(1) PMID: 41946693
- 2. Gao X et al.. 2023. Leptin receptor(+) cells promote bone marrow innervation and regeneration by synthesizing nerve growth factor.. Nat Cell Biol 25(12):1746-1757 PMID: 38012403
- 3. Thoenen H et al.. 1988. Nerve growth factor: cellular localization and regulation of synthesis.. Cell Mol Neurobiol 8(1):35-40 PMID: 3042143
- 4. Takano S et al.. 2017. Nerve growth factor regulation and production by macrophages in osteoarthritic synovium.. Clin Exp Immunol 190(2):235-243 PMID: 28677145
- 5. Maranesi M et al.. 2021. Nerve Growth Factor (NGF) and Animal Reproduction.. Adv Exp Med Biol 1331:277-287 PMID: 34453306
- 6. G El Baassiri M et al.. 2023. Nerve growth factor and burn wound healing: Update of molecular interactions with skin cells.. Burns 49(5):989-1002 PMID: 36379825
- 7. Kanda N et al.. 2003. Histamine enhances the production of nerve growth factor in human keratinocytes.. J Invest Dermatol 121(3):570-7 PMID: 12925217
- 8. Alleva E et al.. 1993. An updated role for nerve growth factor in neurobehavioural regulation of adult vertebrates.. Rev Neurosci 4(1):41-62 PMID: 7952382
